SUSQUEHANNA INTERNATIONAL GROUP, LLP - ELOXX PHARMACEUTICALS INC ownership

ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 40 filers reported holding ELOXX PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 2.09 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of ELOXX PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$3,000
-57.1%
12,100
+2.0%
0.00%
Q1 2022$7,000
-89.1%
11,860
-86.9%
0.00%
Q4 2021$64,000
-86.6%
90,704
-69.1%
0.00%
Q3 2021$479,000
+3.7%
293,844
+26.5%
0.00%
Q2 2021$462,000
-19.2%
232,362
+61.6%
0.00%
Q4 2020$572,000
+420.0%
143,750
+864.0%
0.00%
Q4 2019$110,000
+111.5%
14,912
+28.5%
0.00%
Q3 2019$52,00011,6050.00%
Other shareholders

There were no reported owners of ELOXX PHARMACEUTICALS INC in Q4 2021.

NameSharesValueWeighting ↓
View complete list of ELOXX PHARMACEUTICALS INC shareholders